MilliporeSigma has partnered with IPS-Integrated Project Services, a Blue Bell, Pennsylvania-based engineering firm for the pharmaceutical and biotechnology industries, and G-CON Manufacturing, a College Station, Texas-based manufacturer for cleanroom systems, to develop a 2,000-liter monoclonal antibody (mAb) manufacturing facility and single-use process technology platform.

The deal extends MilliporeSigma’s BioReliance End-to-End offering by integrating MilliporeSigma’s single-use process equipment, end-to-end process development capabilities, and cGMP manufacturing experience into the iCON facility design platform for a turnkey modular facility solution.

The integrated end-to-end offering will deliver a platform for 2,000-L MAb production facilities and would include prefabricated cleanroom units, a structural platform based on pre-engineered building delivery, bioprocess and single-use equipment expertise, as well as turnkey facilities capable of fast-track deployment.

This collaboration adds to MilliporeSigma’s BioReliance End-to-End offering, a suite of products and services to help biopharmaceutical companies accelerate the progression of molecules into the clinic and toward commercialization. The package includes process development, cGMP manufacturing, facility design, equipment for pilot-plant production, process and equipment training, technology transfer, equipment qualification, and set-up for commercialization.

Source: MilliporeSigma